Human medicines European public assessment report (EPAR): Aimovig, erenumab, Date of authorisation: 26/07/2018, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR): Livogiva, teriparatide, Date of authorisation: 27/08/2020, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Kovaltry, octocog alfa, Date of authorisation: 18/02/2016, Revision: 15, Status: Authorised

Radiopharmaceuticals - Scientific guideline

Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 3, Status: Authorised

Draft guideline on quality of radiopharmaceuticals - Revision 2

20th industry stakeholder platform - operation of European Union (EU) pharmacovigilance, Online, European Medicines Agency, Amsterdam, the Netherlands, from 13 November 2025, 13:30 (CET) to 13 November 2025, 17:40 (CET)

Annual open meeting of the European Network of Paediatric Research at EMA (Enpr-EMA) November 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 20 November 2025, 09:00 (CET) to 20 November 2025, 16:45 (CET)

Veterinary medicines European public assessment report (EPAR): Sirolimus TriviumVet , sirolimus, Status: Application withdrawn

EMA procedural advice for medicinal products intended exclusively for markets outside the European Union in the context of co-operation with the World Health Organisation (WHO)